8-K - Eton Pharmaceuticals, Inc. - 1.01 / 2.03 / 9.01

Form 8-K - Current report: SEC Accession No. 0001437749-26-012381

Filing Date: 2026-04-15

Accepted: 2026-04-15 16:05:24

Documents: 13

Period of Report: 2026-04-09

Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

Eton Pharmaceuticals, Inc. (Filer) CIK : 0001710340 (see all company filings) EIN. : 371858472 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 26864166 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | FORM 8-K | eton20260409c_8k.htm iXBRL | 8-K

2 | EXHIBIT 10.1 | ex_943959.htm | EX-10.1

3 | XBRL TAXONOMY EXTENSION SCHEMA | eton-20260409.xsd | EX-101.SCH

4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | eton-20260409_def.xml | EX-101.DEF